Shkreli (Briefly) Kills MNK Stock
Mallinckrodt PLC (NYSE:MNK) took a nosedive, with MNK stock down over eight percent before recovering, following a lawsuit filed against the company over its drug price hiking, delivered by none other than "Pharma Bro" Martin Shkreli.
Mallinckrodt is under fire for using its monopoly to hike prices of a drug treatment for lupus and multiple sclerosis by 2165%, to $28,000 per dose. (Source: ".
Den vollständigen Artikel lesen ...
Mallinckrodt PLC (NYSE:MNK) took a nosedive, with MNK stock down over eight percent before recovering, following a lawsuit filed against the company over its drug price hiking, delivered by none other than "Pharma Bro" Martin Shkreli.
Mallinckrodt is under fire for using its monopoly to hike prices of a drug treatment for lupus and multiple sclerosis by 2165%, to $28,000 per dose. (Source: ".
Den vollständigen Artikel lesen ...